The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Century Medical; Chugai/Roche; Eisai; Lilly; Yakult Honsha
Research Funding - TOWA (Inst)
Final results of adjuvant nivolumab for hepatocellular carcinoma (HCC) after surgical resection (SR) or radiofrequency ablation (RFA) (NIVOLVE): A phase 2 prospective multicenter single-arm trial and exploratory biomarker analysis.
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - BMS; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Ono Pharmaceutical; Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Kazuomi Ueshima
Honoraria - Bayer; Chugai Pharma; EA Pharma; Eisai; Kowa; Lilly Japan; MSD; Sumitomo Group; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Chugai Pharma; Eisai; Lilly Japan; Pfizer; Takeda; Takeda
 
Shin Nakahira
No Relationships to Disclose
 
Naoshi Nishida
No Relationships to Disclose
 
Hiroshi Ida
No Relationships to Disclose
 
Yasunori Minami
No Relationships to Disclose
 
Takuya Nakai
No Relationships to Disclose
 
Hiroshi Wada
No Relationships to Disclose
 
Shoji Kubo
No Relationships to Disclose
 
Kazuyoshi Ohkawa
No Relationships to Disclose
 
Asahiro Morishita
No Relationships to Disclose
 
Takeo Nomi
No Relationships to Disclose
 
Koji Ishida
No Relationships to Disclose
 
Shogo Kobayashi
No Relationships to Disclose
 
Makoto Umeda
No Relationships to Disclose
 
Masakatsu Tsurusaki
No Relationships to Disclose
 
Yasutaka Chiba
No Relationships to Disclose
 
Kenichi Yoshimura
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Eisai; Lilly; Nihonkayaku; Novartis; Otsuka; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - BrightPath Biotheraputics; Nippon Shinyaku
 
Kazuko Sakai
Honoraria - AstraZeneca; Bio-Rad; Chugai Pharma; Roche
 
Kazuto Nishio
Speakers' Bureau - Amgen; AstraZeneca Japan; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Eisai; Guardant Health; Lilly Japan; Merck; MSD K.K.; Novartis; Ono Pharmaceutical; Otsuka; Pfizer; Roche; Sanofi; Solasia Pharma; SymBio Pharmaceuticals
Research Funding - Ignyta; Nippon Boehringer Ingelheim; North East Japan Study Group; Otsuka; Thoracic Oncology Research Group